ArticleKidney international reports2025

The Effects of Clazakizumab on Peripheral Blood and Kidney Transcriptomes in Patients With Late Antibody-Mediated Rejection.

Roy Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.